Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14364833 | 1.00 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2PKMHTT | |
| SCHEMBL69448 | 1.00 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2PKMHTT | |
| SCHEMBL29397907 | 1.00 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2PKMHTT | |
| SCHEMBL30402262 | 1.00 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2PKMHTT | |
| SCHEMBL13843936 | 0.90 | PKM (0.42) | NPC1RAB9ASMN1; SMN2PKMHTT | |
| SCHEMBL13843948 | 0.90 | PKM (0.39) | NPC1RAB9ASMN1; SMN2PKMHTT | |
| SCHEMBL12673228 | 0.90 | PKM (0.50) | NPC1RAB9ASMN1; SMN2PKMHTT | |
| SCHEMBL3256078 | 0.89 | KDM4E (0.47) | NPC1RAB9ASMN1; SMN2PKMALDH1A1 | |
| SCHEMBL12742816 | 0.89 | PKM (0.41) | NPC1RAB9ASMN1; SMN2PKMHTT | |
| SCHEMBL13843947 | 0.89 | DHODH (0.40) | NPC1RAB9ASMN1; SMN2PKMHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121801876-B | Amidase mutant and application thereof in preparation of (S) -penflufen | ZHEJIANG ACADEMY OF AGRICULTURAL SCIENCES (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-121801876-B | Amidase mutant and application thereof in preparation of (S) -penflufen | ZHEJIANG ACADEMY OF AGRICULTURAL SCIENCES (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-121801876-B | Amidase mutant and application thereof in preparation of (S) -penflufen | ZHEJIANG ACADEMY OF AGRICULTURAL SCIENCES (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-121801876-B | Amidase mutant and application thereof in preparation of (S) -penflufen | ZHEJIANG ACADEMY OF AGRICULTURAL SCIENCES (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-121801876-A | Amidase mutant and application thereof in preparation of (S) -penflufen | 浙江省农业科学院 | 2026-04-07 | — | — | CN | disclosed |
| CN-121801876-A | Amidase mutant and application thereof in preparation of (S) -penflufen | 浙江省农业科学院 | 2026-04-07 | — | — | CN | disclosed |
| US-20120077677-A1 | Use of 4-phenylbutyric acid and/or salts thereof for enhancing stress tolerance in plants | BAYER CROPSCIENCE AG (DE) | 2012-03-29 | — | — | US | disclosed |
| US-20070276022-A1 | Optically Active Carboxamides | BAYER CROPSCIENCE AG (DE) | 2007-11-29 | — | — | US | disclosed |
| US-20070276022-A1 | Optically Active Carboxamides | BAYER CROPSCIENCE AG (DE) | 2007-11-29 | — | — | US | disclosed |
| US-20070276022-A1 | Optically Active Carboxamides | BAYER CROPSCIENCE AG (DE) | 2007-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276022-A1 | Optically Active Carboxamides | MRM1, MRPL21, RPIA | NPC1 4211/4885RAB9A 1351/4885SMN1; SMN2 3322/4885 |
| US-20120077677-A1 | Use of 4-phenylbutyric acid and/or salts thereof for enhancing stress tolerance in plants | PAH, ABAT, HPD | NPC1 4148/4885RAB9A 2617/4885SMN1; SMN2 4797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.